129 related articles for article (PubMed ID: 10090671)
21. Becker and Duchenne muscular dystrophy: a comparative morphological study.
Dennett X; Shield LK; Clingan LJ; Woolley DA
Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735
[TBL] [Abstract][Full Text] [Related]
22. Functional significance of dystrophin-positive fibers in Duchenne and Becker muscular dystrophy.
Taşdemir HA; Kotiloğlu E; Topaloğlu H; Kale G; Dinçer DP; Yalaz K; Renda Y
Pediatr Pathol Lab Med; 1996; 16(4):583-90. PubMed ID: 9025855
[TBL] [Abstract][Full Text] [Related]
23. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional activation of the non-muscle, full-length dystrophin isoforms in Duchenne muscular dystrophy skeletal muscle.
Sironi M; Bardoni A; Felisari G; Cagliani R; Robotti M; Comi GP; Moggio M; Bresolin N
J Neurol Sci; 2001 May; 186(1-2):51-7. PubMed ID: 11412872
[TBL] [Abstract][Full Text] [Related]
25. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
Monici MC; Aguennouz M; Mazzeo A; Messina C; Vita G
Neurology; 2003 Mar; 60(6):993-7. PubMed ID: 12654966
[TBL] [Abstract][Full Text] [Related]
26. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
27. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities in the expression of beta-spectrin in Duchenne muscular dystrophy.
Minetti C; Tanji K; Rippa PG; Morreale G; Cordone G; Bonilla E
Neurology; 1994 Jun; 44(6):1149-53. PubMed ID: 8208414
[TBL] [Abstract][Full Text] [Related]
30. Standardized AgNOR analysis in actinic keratosis.
Tuccari G; Giuffrè G; Catalano A; Lentini M; Batolo D
Am J Dermatopathol; 2001 Oct; 23(5):407-12. PubMed ID: 11801772
[TBL] [Abstract][Full Text] [Related]
31. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of standardized AgNOR analysis in early and advanced gastric carcinomas.
Giuffrè G; Caruso RA; Barresi G; Tuccari G
Virchows Arch; 1998 Sep; 433(3):261-6. PubMed ID: 9769130
[TBL] [Abstract][Full Text] [Related]
33. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
Pich A; Chiarle R; Chiusa L; Palestro G
Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
[TBL] [Abstract][Full Text] [Related]
34. Nucleolar argyrophilic proteins in dystrophin-deficient muscles.
Tuccari G; Giuffrè G; Monici MC; Toscano A; Vita G
Muscle Nerve; 1998 Jun; 21(6):830-1. PubMed ID: 9585347
[No Abstract] [Full Text] [Related]
35. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy].
Chuang YH; Jong YJ; Liu KM; Chen SS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780
[TBL] [Abstract][Full Text] [Related]
37. Dystrophin and nebulin in the muscular dystrophies.
Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V
J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133
[TBL] [Abstract][Full Text] [Related]
38. Nucleolar organizer regions (NORs) in adenomyosis.
Madej P; Plewka A; Madej JA; Plewka D; Rutkowski T
Pathol Res Pract; 2006; 202(6):433-7. PubMed ID: 16513291
[TBL] [Abstract][Full Text] [Related]
39. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.
Sundaram C; Uppin MS; Meena AK
Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565
[TBL] [Abstract][Full Text] [Related]
40. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
